IMMX (Immix Biopharma) FCF Margin %: 0.00% (As of Mar. 2026)


IMMX Immix Biopharma Inc IMMX
28 GF Score
Price $9.98
! 2 Warning Signs
View Full Analysis

What is Immix Biopharma FCF Margin %?

Immix Biopharma IMMX +2.57% 28 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates IMMX with a GF Score™ of 28/100. The stock has 2 warning signs investors should review. Among 959 Biotechnology companies, Immix Biopharma ranks worse than 104275.18% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Immix Biopharma's Free Cash Flow for the three months ended in Mar. 2026 was $-9.86 Mil. Immix Biopharma's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Immix Biopharma's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Immix Biopharma's current FCF Yield % is -4.61%.

The historical rank and industry rank for Immix Biopharma's FCF Margin % or its related term are showing as below:


IMMX's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -84.65
* Ranked among companies with meaningful FCF Margin % only.

Immix Biopharma FCF Margin % Related Terms

Immix Biopharma FCF Margin % Historical Data

* Premium members only.

The historical data trend for Immix Biopharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Immix Biopharma FCF Margin % Chart

Immix Biopharma Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Immix Biopharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

IMMX vs PRME, SGP, ACRS: FCF Margin % Comparison

For the Biotechnology subindustry, Immix Biopharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immix Biopharma FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immix Biopharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Immix Biopharma's FCF Margin % falls into.


IMMX
28GF Score
Immix Biopharma Inc IMMX
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Immix Biopharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Immix Biopharma's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-24.663/0
= %

Immix Biopharma's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-9.859/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Immix Biopharma (IMMX) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Immix Biopharma and its competitors. According to the industry distribution chart, Immix Biopharma ranks #999999 out of 959 companies in the Biotechnology industry.
Is Immix Biopharma's FCF Margin % too high?
Immix Biopharma's current FCF Margin % is 0.00%. Based on the distribution chart, Immix Biopharma ranks #999999 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Immix Biopharma has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Immix Biopharma's FCF Margin % compare to PRME and SGP?
According to the Biotechnology industry distribution chart, Immix Biopharma ranks #999999 out of 959 companies for FCF Margin %. This places Immix Biopharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Immix Biopharma and its competitors. Immix Biopharma's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Immix Biopharma stock overvalued right now?
Immix Biopharma (IMMX) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Immix Biopharma's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Immix Biopharma (IMMX), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Immix Biopharma Business Description

Address 11400 West Olympic Boulevard, Suite 200, Los Angeles, CA, USA, 90064
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
28GF Score

Get the complete analysis for IMMX

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.98
Price